Renibus Therapeutics, Inc. — Form D/A
Renibus Therapeutics, Inc. of SOUTHLAKE, TX, a company, filed a Form D amendment with the SEC on 2020-07-15. The offering totals $35.0M, of which $19.8M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-07-15
- Form: D/A
- Accession: 0001667699-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $35.0M
- Amount sold: $19.8M
- Remaining: $15.2M
- Investors: 18
- Date of first sale: 2019-09-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-349442
Issuer
- Name: Renibus Therapeutics, Inc.
- CIK: 0001667699
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 181 GRAND AVE., SUITE 225, SOUTHLAKE, TX, 76092
- Phone: 386-527-1071
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Alvaro Guillem | Executive Officer | Southlake, TX |
| Jamie Jeffrey Donadio | Executive Officer | Southlake, TX |
| Bhupinder Jeffrey Singh | Director | Southlake, TX |
| Bhupinder Jeffrey Singh | Executive Officer | Southlake, TX |
| Carlos Guillem | Director | Southlake, TX |
| Carlos Guillem | Executive Officer | Southlake, TX |
| D. Jeffrey Keyser | Director | Southlake, TX |
| D. Jeffrey Keyser | Executive Officer | Southlake, TX |
| Henrik Jeffrey Rasmussen | Director | Southlake, TX |
| Dale Jones | Director | Argyle, TX |
| Frank Jeffrey Stonebanks | Director | Southlake, TX |
| Frank Jeffrey Stonebanks | Executive Officer | Southlake, TX |
| Alvaro Guillem | Director | Southlake, TX |
| Jennifer D Rasmussen | Director | Lantana, TX |
| Harpreet Kaur | Director | Lantana, TX |
| Harpreet Kaur | Executive Officer | Lantana, TX |
| Nels D Bergmark | Executive Officer | Lantana, TX |
| Jocelyn D Keyser | Director | Lantana, TX |
Other filings by this issuer (13)
More